Comprehensive Quantitative Proteomic Profiling of the Pharmacodynamic Changes Induced By MLN4924 in Acute Myeloid Leukemia Cells Reveals Rational Targets for Combination Therapy
Valeria Visconte(Cleveland Clinic), Jennifer S. Carew(University of Arizona), Sean A. Beausoleil(The University of Texas at San Antonio Health Science Center), Mikkael A. Sekeres(University of Miami), Steffan T. Nawrocki(University of Arizona), Anthony Possemato(Cell Signaling Technology (United States)), Yingchun Han(Shenyang Agricultural University), Anjali S. Advani(Cleveland Clinic), Jaroslaw P. Maciejewski(Cleveland Clinic), Kevin R. Kelly(Keck Hospital of USC), Aziz Nazha, Hetty E. Carraway(Cleveland Clinic)
Cited by 0
Related Papers
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k
Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics
|Clinical Cancer Research|2008|782